Biomea Fusion, Inc.
NASDAQ:BMEABiotechnology
-$0.03 today
- Market cap
- $53.18M
- Beta
- -0.33
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$0.62
Volume 3.50M
Average 1.52M
BMEA Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Biomea Fusion, Inc.NASDAQ: BMEA
Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026
Selling, general & admin declines year over year
Q1 FY2026 selling, general & admin of $3.65M fell 46.4% year over year, behind the -36.6% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 1.4% from the prior quarter. Over 3 fiscal years it compounded at -2.6% a year.
Context
- Selling, general & admin increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 6 analysts of $0 (-100.0%) for the fiscal year ending Dec 2026, a slowdown from the -25.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $3.65M+1.4% QoQ
- Last fiscal yearDec 2025
- $19.33M-25.6% YoY
- LTMMar 2026
- $16.17M-36.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -46.4% | -100.0% | -53.6 pp |
| 1 year | -25.6% | -100.0% | -74.4 pp |
| 3-year CAGR | -2.6% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 19.33M USD
- Year-over-year change
- -25.6%
- 4-year CAGR
- +9.0%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 19.33M | -25.6% |
| FY2024 | 2024-12-31 | 25.99M | +10.2% |
| FY2023 | 2023-12-31 | 23.59M | +12.8% |
| FY2022 | 2022-12-31 | 20.92M | +53.0% |
| FY2021 | 2021-12-31 | 13.67M | — |
Selling, General & Admin vs competitors
How BMEA compares with its peers on the latest reported figures
- BMEA's LTM Mar 2026 selling, general & admin of $16.17M is the 8th highest of the 9 companies compared; the peer median is $21.34M.
- Its year-over-year change of -36.6% is the 7th highest of 8, against a peer median of -23.4%.
- Over three fiscal years its annual growth of -2.6% compares with a peer median of +11.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $35.33M | -27.9% | -11.7% | 35.5% | |
| LTM Mar 2026 | $23.53M | +30.1% | +11.7% | — | |
CBUSCibus, Inc. | LTM Mar 2026 | $22.13M | -30.7% | +41.8% | 516.4% |
| LTM Mar 2026 | $21.4M | +37.8% | +45.9% | — | |
| LTM Mar 2026 | $21.28M | -23.4% | -6.3% | — | |
| LTM Mar 2026 | $17.75M | +13.9% | — | 451.2% | |
| LTM Mar 2026 | $17.25M | — | +15.2% | — | |
| LTM Mar 2026 | $16.17M | -36.6% | -2.6% | — | |
| LTM Mar 2026 | $15.9M | -38.9% | -12.9% | — | |
| Peer median (excluding BMEA) | $21.34M | -23.4% | +11.7% | 451.2% | |
Competitors are the stored peer set for BMEA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 1.41M |
| Gross Profit | 0 | 0 | 0 | 0 | (1.41M) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 28M | 62.71M | 102.55M | 118.09M | 61.98M |
| Selling, General & Admin | 13.67M | 20.92M | 23.59M | 25.99M | 19.33M |
| Operating Expenses | 41.67M | 83.63M | 126.14M | 144.07M | 79.9M |
| Depreciation & Amortization | 249K | 691K | 1.52M | 1.75M | 1.41M |
| EBITDA | (41.32M) | (81.14M) | (115.74M) | (136.68M) | (60.39M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (41.67M) | (83.63M) | (126.14M) | (144.07M) | (81.31M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 100K | 1.81M | 8.88M | 5.64M | 1.86M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 100K | 1.81M | 8.88M | 5.64M | 19.51M |
| Income Before Tax | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| EPS (Diluted) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| Weighted Avg Shares | 23.86M | 29.27M | 34.11M | 36.11M | 52.23M |
| Weighted Avg Shares (Diluted) | 23.86M | 29.27M | 34.11M | 36.11M | 52.23M |
Biomea Fusion, Inc.
NASDAQ:BMEA
Intrinsic Alpha fair value
Locked
Current Price
$0.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.